Top Page
C21 Investments
(OTC:CXXI)
C21 Investments (CXXI) vs. iShares MSCI Canada ETF (EWC)
C21 Investments Business Overview & Revenue Model
C21 Investments Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2023 | Dec 2022 | Dec 2022 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.08M | 30.12M | 28.29M | 32.98M | 28.89M | 37.70M |
| Gross Profit | 13.51M | 12.56M | 11.15M | 18.81M | 13.40M | 13.32M |
| EBITDA | 4.57M | 2.90M | 2.63M | 20.72M | 6.98M | -19.56M |
| Net Income | -3.32M | -3.97M | -3.31M | 9.96M | 293.21K | -32.56M |
Balance Sheet | ||||||
| Total Assets | 56.40M | 57.00M | 54.53M | 61.85M | 58.31M | 61.45M |
| Cash, Cash Equivalents and Short-Term Investments | 2.66M | 2.63M | 2.41M | 3.07M | 1.89M | 3.08M |
| Total Debt | 12.88M | 13.15M | 10.72M | 18.67M | 12.14M | 36.07M |
| Total Liabilities | 28.50M | 28.32M | 23.48M | 26.87M | 24.00M | 47.87M |
| Stockholders Equity | 27.90M | 28.68M | 31.05M | 34.98M | 34.32M | 13.58M |
Cash Flow | ||||||
| Free Cash Flow | 844.24K | -2.63M | 5.46M | 4.27M | 5.46M | 5.00M |
| Operating Cash Flow | 1.12M | 1.19M | 5.90M | 6.84M | 5.90M | 5.51M |
| Investing Cash Flow | 423.26K | -3.12M | -390.93K | -1.39M | -390.93K | -4.54M |
| Financing Cash Flow | -2.02M | 1.27M | -6.68M | -7.84M | -6.68M | -7.10M |
C21 Investments Technical Analysis
C21 Investments Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | C$23.55M | 13.51 | 6.23% | ― | 34.71% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | C$59.44M | ― | -21.73% | ― | 43.56% | -349.41% | |
48 Neutral | $33.25M | 183.33 | 7.78% | ― | 28.55% | ― | |
44 Neutral | C$19.83M | ― | -15.75% | ― | 26.75% | 61.79% | |
43 Neutral | C$82.83M | ― | -9.90% | ― | 23.29% | 33.65% | |
41 Neutral | $28.86M | -18.28 | -77.67% | ― | 2.41% | 74.61% |
C21 Investments Corporate Events
C21 Investments reported a strong financial performance in its second quarter, with a 13% increase in revenue to $8.5 million, driven by a 15% rise in same store sales. Despite a challenging market and a 16% decline in Nevada sales, the company achieved a record number of retail transactions and improved its gross margin to 50.4%. The company’s strategic shift to reduce wholesale exposure and focus on retail sales resulted in a substantial improvement in adjusted EBITDA and positive free cash flow, highlighting its robust business model and growth trajectory.
The most recent analyst rating on (TSE:CXXI) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on C21 Investments stock, see the TSE:CXXI Stock Forecast page.
C21 Investments Inc. announced it will release its second-quarter financial results on November 11, 2025. This announcement is significant for stakeholders as it provides insights into the company’s financial health and performance, which could impact its operations and market positioning in the cannabis industry.
The most recent analyst rating on (TSE:CXXI) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on C21 Investments stock, see the TSE:CXXI Stock Forecast page.
On September 8, 2025, C21 Investments Inc. announced the issuance of 100,000,000 Subordinate Voting Shares at a nominal price to maintain its status as a ‘foreign private issuer’ under U.S. securities law. This move is intended to reduce compliance costs and does not result in a change of control for the company.
The most recent analyst rating on (TSE:CXXI) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on C21 Investments stock, see the TSE:CXXI Stock Forecast page.
C21 Investments Inc. has completed a transaction to create and issue a new class of subordinate voting shares, designed to maintain its status as a foreign private issuer in the United States and reduce compliance costs. This move is strategic for the company as it ensures no impact on the economic or voting rights of existing common shareholders, while providing flexibility in share structure and maintaining regulatory compliance.
The most recent analyst rating on (TSE:CXXI) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on C21 Investments stock, see the TSE:CXXI Stock Forecast page.
C21 Investments Inc. has reached a settlement agreement regarding litigation involving its subsidiary Eco Firma Farms, resolving disputes with Proudest Monkey Holdings and its owners. The settlement, which includes a cash payment of $2.4 million and issuance of company shares, will dismiss all claims and offset certain financial liabilities, potentially stabilizing C21’s financial position and allowing it to focus on its core business operations.
The most recent analyst rating on (TSE:CXXI) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on C21 Investments stock, see the TSE:CXXI Stock Forecast page.
C21 Investments Inc. has announced its upcoming Annual General Meeting of shareholders, scheduled for September 23, 2025, in Vancouver, British Columbia. The meeting will address several key issues, including the presentation of audited financial statements for the year ending March 31, 2025, the election of four directors, and the appointment of an auditor for the upcoming year. Shareholders of record as of July 30, 2025, are eligible to vote, and those unable to attend in person are encouraged to submit their proxies by September 19, 2025. This meeting is crucial for stakeholders as it will shape the company’s governance and financial oversight for the coming year.
The most recent analyst rating on (TSE:CXXI) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on C21 Investments stock, see the TSE:CXXI Stock Forecast page.